Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which "reset the bar" for future trials of ...

Please provide your email address to receive an email when new articles are posted on . HPV testing rates in oropharyngeal cancer have increased over time but remain suboptimal. Testing uptake varies ...

Treatment deintensification for human papillomavirus–positive (HPV+)-associated oropharyngeal cancer (OPC) has been the catalyst of experts worldwide. In situ hybridization is optimal to identify HPV+ ...

A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in ...

November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...

March 30, 2010 — The incidence of oropharyngeal carcinoma related to human papillomavirus (HPV) has been increasing in recent years, and there is speculation that this is the result of the "sexual ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancers — tumors of the back of the mouth and throat — is rising. If caught early, most of these cancers have a high survival rate, ...

Throat cancer patients exposed to both human papillomavirus (HPV) and tobacco smoke demonstrate a pattern of mutations along several key cancer genes, according to research presented today at the 2016 ...

Teams of head and neck radiation oncologists, surgical oncologists and medical oncologists at Memorial Sloan Kettering Cancer Center (MSK) recently published two retrospective studies with ...

Just months after sharing that he was cancer-free, “Full House” actor Dave Coulier says he has been diagnosed with a ...